Guidelines in Cardio-Oncology: The Balance Between Evidence and Expert Opinion

被引:0
作者
Leedy, Douglas J. [1 ]
Alhama-Belotto, Marta [1 ]
Gwin III, William R. [2 ]
Kapoor, Ruchi [1 ]
Minami, Elina [1 ]
Chow, Eric J. [3 ]
Cheng, Richard K. [1 ]
机构
[1] Univ Washington, Med Ctr, Div Cardiol, Seattle, WA 98195 USA
[2] Univ Washington, Med Ctr, Div Med Oncol, Seattle, WA USA
[3] Fred Hutchinson Canc Ctr, Clin Res & Publ Hlth Sci Div, Seattle, WA USA
关键词
Cardio-oncology; Guidelines; Cardiology; Oncology; Evidence-based medicine; Expert opinion; CLINICAL-PRACTICE GUIDELINES; CARDIOLOGY/AMERICAN HEART ASSOCIATION; ADJUVANT TRASTUZUMAB; AMERICAN SOCIETY; CANCER-TREATMENT; MANAGEMENT; CONSENSUS; THERAPY; COLLEGE;
D O I
10.1007/s11936-023-01014-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose of reviewWhile expert opinion is an important tool in the development of clinical practice guidelines (CPGs), it must be used judiciously and balanced with the available evidence. In this review, we carefully examine the role of balancing evidence and expert opinion in the context of the 2022 European Society of Cardiology (ESC) Cardio-Oncology guidelines, including the factors that influence the weight given to expert opinion and potential impact on health care systems adhering to specific guideline recommendations.Recent findingsIn an attempt to be all-encompassing, the 2022 ESC guidelines risk diluting important recommendations with low-quality recommendations lacking consensus. Adherence to, as well as deviation from, guidelines may have important unintended consequences to stakeholders.SummaryThe 2022 ESC guidelines should be viewed as a catalyst for the cardio-oncology community to generate higher quality evidence to address existing gaps in knowledge while also recognizing the current constraints in providing care to patients with cancer.
引用
收藏
页码:639 / 654
页数:16
相关论文
共 55 条
[1]   Spectrum of National Institutes of Health - Funded Research in Cardio - Oncology A Basic, Clinical, and Observational Science Perspective [J].
Adhikari, Bishow B. ;
Shi, Scarlet ;
Dimond, Eileen P. ;
Shelburne, Nonniekaye ;
Desvigne-Nickens, Patrice ;
Minasian, Lori M. .
HEART FAILURE CLINICS, 2022, 18 (03) :515-528
[2]   Cardiovascular Toxicity Related to Cancer Treatment: A Pragmatic Approach to the American and European Cardio-Oncology Guidelines [J].
Alexandre, Joachim ;
Cautela, Jennifer ;
Ederhy, Stephane ;
Damaj, Ghandi Laurent ;
Salem, Joe-Elie ;
Barlesi, Fabrice ;
Farnault, Laure ;
Charbonnier, Aude ;
Mirabel, Mariana ;
Champiat, Stephane ;
Cohen-Solal, Alain ;
Cohen, Ariel ;
Dolladille, Charles ;
Thuny, Franck .
JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2020, 9 (18)
[3]   Cardio-Oncology Education and Training JACC Council Perspectives [J].
Alvarez-Cardona, Jose A. ;
Ray, Jordan ;
Carver, Joseph ;
Zaha, Vlad ;
Cheng, Richard ;
Yang, Eric ;
Mitchell, Joshua D. ;
Stockerl-Goldstein, Keith ;
Kondapalli, Lavanya ;
Dent, Susan ;
Arnold, Anita ;
Brown, Sherry Ann ;
Leja, Monica ;
Barac, Ana ;
Lenihan, Daniel J. ;
Herrmann, Joerg .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 76 (19) :2267-2281
[4]   ACC/AHA Statement on Cost/Value Methodology in Clinical Practice Guidelines and Performance Measures A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines [J].
Anderson, Jeffrey L. ;
Heidenreich, Paul A. ;
Barnett, Paul G. ;
Creager, Mark A. ;
Fonarow, Gregg C. ;
Gibbons, Raymond J. ;
Halperin, Jonathan L. ;
Hlatky, Mark A. ;
Jacobs, Alice K. ;
Mark, Daniel B. ;
Masoudi, Frederick A. ;
Peterson, Eric D. ;
Shaw, Leslee J. .
CIRCULATION, 2014, 129 (22) :2329-+
[5]   Managing hypertension in 2018: which guideline to follow? [J].
Angeli, Fabio ;
Reboldi, Gianpaolo ;
Trapasso, Monica ;
Aita, Adolfo ;
Verdecchia, Paolo .
HEART ASIA, 2019, 11 (01)
[6]   Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline [J].
Armenian, Saro H. ;
Lacchetti, Christina ;
Barac, Ana ;
Carver, Joseph ;
Constine, Louis S. ;
Denduluri, Neelima ;
Dent, Susan ;
Douglas, Pamela S. ;
Durand, Jean-Bernard ;
Ewer, Michael ;
Fabian, Carol ;
Hudson, Melissa ;
Jessup, Mariell ;
Jones, Lee W. ;
Ky, Bonnie ;
Mayer, Erica L. ;
Moslehi, Javid ;
Oeffinger, Kevin ;
Ray, Katharine ;
Ruddy, Kathryn ;
Lenihan, Daniel .
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (08) :893-U144
[7]  
Asteggiano R., 2020, CARDIOLOGY CARE DELI, DOI [10.1093/eurheartj/ehz935, DOI 10.1093/EURHEARTJ/EHZ935]
[8]   Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events [J].
Brahmer, Julie R. ;
Abu-Sbeih, Hamzah ;
Ascierto, Paolo Antonio ;
Brufsky, Jill ;
Cappelli, Laura C. ;
Cortazar, Frank B. ;
Gerber, David E. ;
Hamad, Lamya ;
Hansen, Eric ;
Johnson, Douglas B. ;
Lacouture, Mario E. ;
Masters, Gregory A. ;
Naidoo, Jarushka ;
Nanni, Michele ;
Perales, Miguel-Angel ;
Puzanov, Igor ;
Santomasso, Bianca D. ;
Shanbhag, Satish P. ;
Sharma, Rajeev ;
Skondra, Dimitra ;
Sosman, Jeffrey A. ;
Turner, Michelle ;
Ernstoff, Marc S. .
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (06)
[9]   Bridging the gap to advance the care of individuals with cancer: collaboration and partnership in the Cardiology Oncology Innovation Network (COIN) [J].
Brown, Sherry-Ann ;
Beavers, Craig ;
Martinez, Hugo R. ;
Marshall, Catherine H. ;
Olaye, Iredia M. ;
Guha, Avirup ;
Cho, David ;
Bailey, Alison ;
Bergom, Carmen ;
Bansal, Neha ;
Bauer, Brenton ;
Cheng, Richard K. .
CARDIO-ONCOLOGY, 2022, 8 (01)
[10]   Why don't physicians follow clinical practice guidelines? A framewouk for improvement [J].
Cabana, MD ;
Rand, CS ;
Powe, NR ;
Wu, AW ;
Wilson, MH ;
Abboud, PAC ;
Rubin, HR .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (15) :1458-1465